2-氨基-4-亚甲基环戊烷e羧酸 | 156292-16-9

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 2-氨基-4-亚甲基环戊烷e羧酸
• 英文名称: (+)-(1S,2R)-2-Amino-4-methylene-cyclopentane-1-carboxylic acid
• 英文别名: (1S,2R)-2-amino-4-methylene-cyclopentanecarboxylic acid；(1S,2R)-2-amino-4-methylidenecyclopentane-1-carboxylic acid
• CAS: 156292-16-9；786615-32-5
• 化学式: C₇H₁₁NO₂
• 分子量: 141.17
• InChiKey: RKOUGZGFAYMUIO-NTSWFWBYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -2.1
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  63.3
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  (E)-Cinnamyl (1S,2R)-2-N-((E)-cinnamyloxycarbonyl)amino-4-methylene-1-cyclopentane-carboxylate 在 吗啉 、 palladium diacetate 、 三苯基膦 作用下， 以 乙醇 为溶剂， 生成 2-氨基-4-亚甲基环戊烷e羧酸
  参考文献：
  名称：

  Novel antifungal β-amino acids: synthesis and activity against Candida albicans

  摘要：

  A series of novel beta-amino acids has been synthesized and tested for their in vitro antifungal activity against Candida albicans. A steep SAR was observed. beta-Amino acid 21 (BAY 10-8888/PLD-118) revealed the most favourable activity-tolerability profile and was selected for clinical studies as a novel antifungal for the oral treatment of yeast infections. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(02)00958-7

文献信息

• Effizientes und hochenantioselektives Verfahren zur Herstellung von enantiomerenreinen Cyclopentan-beta-Aminosäuren
  申请人：BAYER AG

  公开号：EP0805145B1

  公开（公告）日：2001-10-31
• US5877343A
  申请人：——

  公开号：US5877343A

  公开（公告）日：1999-03-02
• Novel antifungal β-amino acids: synthesis and activity against Candida albicans
  作者：Joachim Mittendorf、Franz Kunisch、Michael Matzke、Hans-Christian Militzer、Axel Schmidt、Wolfgang Schönfeld

  DOI：10.1016/s0960-894x(02)00958-7

  日期：2003.2

  A series of novel beta-amino acids has been synthesized and tested for their in vitro antifungal activity against Candida albicans. A steep SAR was observed. beta-Amino acid 21 (BAY 10-8888/PLD-118) revealed the most favourable activity-tolerability profile and was selected for clinical studies as a novel antifungal for the oral treatment of yeast infections. (C) 2002 Elsevier Science Ltd. All rights reserved.